NTLA
Price
$12.05
Change
-$0.05 (-0.41%)
Updated
Dec 24, 02:00 PM (EDT)
58 days until earnings call
TRVI
Price
$4.00
Change
-$0.06 (-1.48%)
Updated
Dec 24, 02:00 PM (EDT)
85 days until earnings call
Ad is loading...

NTLA vs TRVI

Header iconNTLA vs TRVI Comparison
Open Charts NTLA vs TRVIBanner chart's image
Intellia Therapeutics
Price$12.05
Change-$0.05 (-0.41%)
Volume$68.49K
CapitalizationN/A
Trevi Therapeutics
Price$4.00
Change-$0.06 (-1.48%)
Volume$57.27K
CapitalizationN/A
NTLA vs TRVI Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. TRVI commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and TRVI is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (NTLA: $12.05 vs. TRVI: $4.00)
Brand notoriety: NTLA and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 30% vs. TRVI: 20%
Market capitalization -- NTLA: $1.23B vs. TRVI: $357.46M
NTLA [@Biotechnology] is valued at $1.23B. TRVI’s [@Biotechnology] market capitalization is $357.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while TRVI’s TA Score has 5 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 4 bearish.
  • TRVI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both NTLA and TRVI are a good buy in the short-term.

Price Growth

NTLA (@Biotechnology) experienced а -8.23% price change this week, while TRVI (@Biotechnology) price change was -11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 20, 2025.

TRVI is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.23B) has a higher market cap than TRVI($357M). TRVI YTD gains are higher at: 202.985 vs. NTLA (-60.315). TRVI has higher annual earnings (EBITDA): -44.19M vs. NTLA (-527.52M). NTLA has more cash in the bank: 658M vs. TRVI (65.5M). TRVI has less debt than NTLA: TRVI (1.11M) vs NTLA (102M). NTLA has higher revenues than TRVI: NTLA (43.1M) vs TRVI (0).
NTLATRVINTLA / TRVI
Capitalization1.23B357M344%
EBITDA-527.52M-44.19M1,194%
Gain YTD-60.315202.985-30%
P/E RatioN/AN/A-
Revenue43.1M0-
Total Cash658M65.5M1,005%
Total Debt102M1.11M9,164%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLATRVI
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRLCX18.860.16
+0.86%
Voya Large Cap Growth Port R6
LEXCX62.480.14
+0.22%
Voya Corporate Leaders Trust B
CVSOX14.920.01
+0.09%
Calamos Market Neutral Income R6
HSSCX22.80N/A
N/A
Emerald Finance & Bking Innovt Fd C
GURAX32.37N/A
N/A
NAA Risk Managed Real Estate A

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-0.66%
VCYT - NTLA
69%
Closely correlated
+0.24%
EDIT - NTLA
68%
Closely correlated
-4.58%
BEAM - NTLA
65%
Loosely correlated
-1.07%
CRSP - NTLA
62%
Loosely correlated
-0.59%
PRME - NTLA
58%
Loosely correlated
-3.10%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with CMPX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then CMPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+0.25%
CMPX - TRVI
37%
Loosely correlated
+9.42%
BEAM - TRVI
32%
Poorly correlated
-1.07%
AURA - TRVI
32%
Poorly correlated
-0.24%
NTLA - TRVI
31%
Poorly correlated
-0.66%
ABCL - TRVI
31%
Poorly correlated
+2.46%
More